Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Infection and Immunity|February 1, 1973
Ultrastructure of Ehrlichia canisP K Hildebrandt, J D Conroy, A E McKee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted TherapiesJulia A Beaver, Abraham Tzou, Gideon M Blumenthal, et al.
Biochemical and Biophysical Research Communications|July 30, 1999
Expression and purification of recombinant human granzyme B from Pichia pastorisJ Sun, C H Bird, M S Buzza, et al.
Medicine and Science in Sports and Exercise|October 22, 2025
Creating and Evaluating a Prediction Equation for VO2peak in Individuals with Early Stage, Never Medicated Parkinson's DiseaseGarett J Griffith, Brandi Thomsen, Zepei Xie, et al.
The Oncologist|April 26, 2019
U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular RemissionE Dianne Pulte, Tanya Wroblewski, Erik Bloomquist, et al.
The Oncologist|February 14, 2018
FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaElizabeth Dianne Pulte, Andrew Dmytrijuk, Lei Nie, et al.
Neuroscience|April 12, 2016
Removal of high-fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female miceJesse L Carlin, Sarah E McKee, Tiffany Hill-Smith, et al.
Genome Biology|August 9, 2007
Exon expression profiling reveals stimulus-mediated exon use in neural cellsAdrienne E McKee, Nicola Neretti, Luis E Carvalho, et al.
The Oncologist|July 19, 2018
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic LeukemiaE Dianne Pulte, Jonathon Vallejo, Donna Przepiorka, et al.
The Oncologist|August 19, 2018
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1Lola Fashoyin-Aje, Martha Donoghue, Huanyu Chen, et al.
Pageof 15